PEGylated silica nanoparticles encapsulating multiple magnetite nanocrystals for high-performance microscopic magnetic resonance angiography

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 99 B, Issue 1, 2011, Pages 81-88

  Wu, Si Han ^a   Lin, Chien Yuan ^b   Hung, Yann ^a   Chen, Wei ^a   Chang, Chen ^b   Mou, Chung Yuan ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

contrast agents; Fe 3O 4; MRI; polyethylene glycol; silica

Indexed keywords

BLOOD POOL; CEREBRAL BLOOD VOLUME; CIRCULATION TIME; CLINICAL DIAGNOSIS; CONTRAST AGENT; HIGH RESOLUTION; INTRAVASCULAR; MAGNETIC RESONANCE ANGIOGRAPHY; MR IMAGES; RELAXIVITY; SILICA NANOPARTICLES; SILICA SHELL;

ANGIOGRAPHY; BLOOD; DIAGNOSIS; ETHYLENE; GLYCOLS; IRON ORES; LAKES; NANOCRYSTALS; NANOMAGNETICS; NANOPARTICLES; POLYETHYLENE GLYCOLS; SILICA; SILICON COMPOUNDS; THREE DIMENSIONAL;

MAGNETIC RESONANCE;

CONTRAST MEDIUM; MACROGOL; MAGNETITE NANOPARTICLE; NANOCRYSTAL; SILICON;

ARTICLE; CIRCULATION TIME; CONTROLLED STUDY; CYTOTOXICITY; ENCAPSULATION; FEMALE; HEMOLYSIS; HIGH PERFORMANCE MICROSCOPIC MAGNETIC RESONANCE ANGIOGRAPHY; HUMAN; HUMAN CELL; MAGNETIC RESONANCE ANGIOGRAPHY; MICROVASCULATURE; NONHUMAN; OPSONIZATION; RAT; SYNTHESIS;

ANIMALS; CEREBROVASCULAR CIRCULATION; DEXTRANS; FERUMOXYTOL; HELA CELLS; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETITE NANOPARTICLES; MATERIALS TESTING; MICE; MICROVESSELS; NANOPARTICLES; POLYETHYLENE GLYCOLS; RATS; SILICON DIOXIDE;

EID: 80052341294     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31874     Document Type: Article

References (33)

1. Jun YW, Lee JH, Cheon J,. Chemical design of nanoparticle probes for high-performance magnetic resonance imaging. Angew Chem Int Ed 2008; 47: 5122-5135.
2. Na HB, Song IC, Hyeon T,. Inorganic nanoparticles for MRI contrast agents. Adv. Mater 2009; 21: 2133-2148.
3. Corot C, Robert P, Idee JM, Port M,. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 2006; 58: 1471-1504. (Pubitemid 44820503)
4. Veiseh O, Gunn JW, Zhang MQ,. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev 2010; 62: 284-304.
5. Chomoucka J, Drbohlavova J, Huska D, Adam V, Kizek R, Hubalek J,. Magnetic nanoparticles and targeted drug delivering. Pharmacol. Res 2010; 62: 144-149.
6. Lee JH, Jun YW, Yeon SI, Shin JS, Cheon J,. Dual-mode nanoparticle probes for high-performance magnetic resonance and fluorescence imaging of neuroblastoma. Angew Chem Int Ed 2006; 45: 8160-8162. (Pubitemid 44974152)
7. Jun YW, Huh YM, Choi JS, Lee JH, Song HT, Kim S, Yoon S, Kim KS, Shin JS, Suh JS, Cheon J,. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J Am Chem Soc 2005; 127: 5732-5733. (Pubitemid 40577599)
8. 4 nanoparticles for reduced non-specific uptake by macrophage cells. Adv Mater 2007; 19: 3163-3166. (Pubitemid 350044454)
9. 2 nanoparticles via bioinspired silicification for magnetic resonance imaging. Adv Funct Mater 2010; 20: 722-731.
10. Tanaka K, Narita A, Kitamura N, Uchiyama W, Morita M, Inubushi T, Chujo Y,. Preparation for highly sensitive MRI contrast agents using core/shell type nanoparticles consisting of multiple SPIO cores with thin silica coating. Langmuir 2010; 26: 11759-11762.
11. Lin CY, Lin MH, Cheung WM, Lin TN, Chen JH, Chang C,. In vivo cerebromicrovasculatural visualization using 3D Delta R-2-based microscopy of magnetic resonance angiography (3D Delta R-2-mMRA). Neuroimage 2009; 45: 824-831.
12. Bagwe RP, Yang CY, Hilliard LR, Tan WH,. Optimization of dye-doped silica nanoparticles prepared using a reverse microemulsion method. Langmuir 2004; 20: 8336-8342.
13. Josephson L, Perez JM, Weissleder R,. Magnetic nanosensors for the detection of oligonucleotide sequences. Angew Chem Int Ed 2001; 40: 3204-3206. (Pubitemid 32845396)
14. Perez JM, Simeone FJ, Saeki Y, Josephson L, Weissleder R,. Viral-induced self-assembly of magnetic nanoparticles allows the detection of viral particles in biological media. J Am Chem Soc 2003; 125: 10192-10193. (Pubitemid 37022228)
15. Perez JM, Josephson L, O'Loughlin T, Hogemann D, Weissleder R,. Magnetic relaxation switches capable of sensing molecular interactions. Nat Biotechnol 2002; 20: 816-820. (Pubitemid 34836759)
16. Brittain WJ, Minko S,. A structural definition of polymer brushes. J Polym Sci A Polym Chem 2007; 45: 3505-3512. (Pubitemid 47311786)
17. Owens DE, Peppas NA,. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006; 307: 93-102. (Pubitemid 41773257)
18. Sun SH, Zeng H,. Size-controlled synthesis of magnetite nanoparticies. J Am Chem Soc 2002; 124: 8204-8205.
19. Gossuin Y, Gillis P, Hocq A, Vuong QL, Roch A,. Magnetic resonance relaxation properties of superparamagnetic particles. WIREs Nanomed. Nanobiotechnology 2009; 1: 299-310.
20. Wu SH, Lin YS, Hung Y, Chou YH, Hsu YH, Chang C, Mou CY,. Multifunctional mesoporous silica nanoparticles for intracellular labeling and animal magnetic resonance imaging studies. Chembiochem 2008; 9: 53-57.
21. Mitragotri S, Lahann J,. Physical approaches to biomaterial design. Nat Mater 2009; 8: 15-23.
22. Nel AE, Madler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, Klaessig F, Castranova V, Thompson M,. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 2009; 8: 543-557.
23. Storm G, Belliot SO, Daemen T, Lasic DD,. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Deliv Rev 1995; 17: 31-48.
24. Pasut G, Veronese FM,. PEG conjugates in clinical development or use as anticancer agents: An overview. Adv Drug Deliv Rev 2009; 61: 1177-1188.
25. Caliceti P, Veronese FM,. Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates. Adv Drug Deliv Rev 2003; 55: 1261-1277. (Pubitemid 37464561)
26. Allen C, Dos Santos N, Gallagher R, Chiu GNC, Shu Y, Li WM, Johnstone SA, Janoff AS, Mayer LD, Webb MS, Bally MB,. Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol). Biosci Rep 2002; 22: 225-250. (Pubitemid 35222733)
27. Alexis F, Pridgen E, Molnar LK, Farokhzad OC,. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 2008; 5: 505-515.
28. Lin YS, Haynes CL,. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. J Am Chem Soc 2010; 132: 4834-4842.
29. He QJ, Zhang JM, Shi JL, Zhu ZY, Zhang LX, Bu WB, Guo LM, Chen Y,. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials 2010; 31: 1085-1092.
30. Zhao Y, Sun X, Zhang G, Trewyn BG, Slowing II, Lin VSY,. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: Size and surface effects. ACS Nano 2011; 5: 1366-1375.
31. Tsai CP, Chen CY, Hung Y, Chang FH, Mou CY,. Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells. J Mater Chem 2009; 19: 5737-5743.
32. Lee JE, Lee N, Kim H, Kim J, Choi SH, Kim JH, Kim T, Song IC, Park SP, Moon WK, Hyeon T,. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. J Am Chem Soc 2010; 132: 552-557.
33. Villaraza AJL, Bumb A, Brechbiel MW,. Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics. Chem Rev 2010; 110: 2921-2959.